Fast Market Research

Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013: New Research Report Available at Fast Market Research

Fast Market Research recommends "Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013" from Global Markets Direct, now available

 
Repost This

Boston, MA -- (SBWIRE) -- 02/12/2014 -- Global Market Direct's pharmaceuticals report, "Yakult Honsha Co., Ltd. - Product Pipeline Review - 2013" provides data on the Yakult Honsha Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Yakult Honsha Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Yakult Honsha Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Yakult Honsha Co., Ltd. - Brief Yakult Honsha Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Yakult Honsha Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Yakult Honsha Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Yakult Honsha Co., Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Yakult Honsha Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Yakult Honsha Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Yakult Honsha Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Yakult Honsha Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Yakult Honsha Co., Ltd. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Yakult Honsha Co., Ltd.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Yakult Honsha Co., Ltd. (2267) - Financial and Strategic SWOT Analysis Review
- AEterna Zentaris Inc. - Product Pipeline Review - 2013
- Celsion Corporation - Product Pipeline Review - 2013
- Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2013
- Novo Nordisk A/S - Product Pipeline Review - 2013
- Metastatic Pancreatic Cancer - Pipeline Review, H2 2013
- Evotec AG - Product Pipeline Review - 2013
- Cancer Pain - Pipeline Review, H2 2013
- Actelion Ltd - Product Pipeline Review - 2013
- Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2013